Go Pro

iShares Biotechnology ETF (IBB) News Today

iShares Biotechnology ETF logo
$192.06 -5.28 (-2.68%)
As of 07/10/2026 04:00 PM Eastern

IBB Latest News

Illustrated trading room with two silhouetted figures viewing multiple screens showing declining and rising stock charts across tech, utilities, healthcare, and retail sectors.
5 Places Investors Can Hide If the AI Trade Keeps Cracking
As AI stocks face volatility, capital is rotating into biotech, industrials, utilities, consumer staples, and dividend ETFs showing relative strength.
A laptop displaying an upward-trending multi-line stock chart sits on a wooden desk beside a coffee mug and smartphone.
MarketBeat Week in Review – 06/22 - 06/26 (IBB)
SpaceX IPO buzz faded as AI volatility, hotter inflation, and a shortened trading week shifted investor focus toward earnings season...
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.
The iShares Nasdaq Biotechnology ETF (IBB) is trading just 1.47% below its 52-week high, signaling a potential multi-year sector breakout.
2 Ways to Play the Big Pharma Patent Cliff (IBB)
With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize.
IBB: Beyond The 2025 Surge, Biotech Breakout
IBB: Biotech's Hot Streak May Cool
Funding for Risky Biotechs Is Returning
Daily ETF Flows: Biotech ETF "IBB" Makes The Cut
2 Top Growth Themes Beyond AI and How to Invest in Them
2 Top Growth Themes Beyond AI and How to Invest in Them
2 Brilliant Biotech ETFs to Watch in 2026
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing (IBB)
The healthcare sector is outperforming the broader market and tech sector in Q4, confirming a substantial capital shift into the defensive industry.
IBB: Biotech's Leading Players, All In One ETF
Biotech Sector May Flip to Market Leader by Year-End (IBB)
As rate cuts loom and after years of lagging, the biotech sector is showing signs of life, with IBB outpacing the benchmark S&P 500 on the quarter.
IBB: Now Is The Time To Be Contrarian
Top-rated biotechs with negative enterprise values
Get iShares Biotechnology ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IBB Media Mentions By Week

IBB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IBB
News Sentiment

1.53

0.78

Average
Finance
News Sentiment

IBB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IBB Articles
This Week

2

1

IBB Articles
Average Week

Get the Latest News and Ratings for IBB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:IBB) was last updated on 7/11/2026 by MarketBeat.com Staff.
From Our Partners